Mirtazapine for Anxiety Treatment
Mirtazapine is effective for treating anxiety and can be used as a therapeutic option, particularly when anxiety co-occurs with depression, sleep disturbances, or in patients with cardiovascular disease. 1, 2
Efficacy for Anxiety
- Mirtazapine has demonstrated efficacy for treating depression with accompanying anxiety symptoms, with moderate strength of evidence according to the American College of Physicians 2
- It shows beneficial anxiolytic effects that can appear early in treatment, making it suitable for patients requiring prompt symptom relief 3
- Mirtazapine has shown effectiveness in various anxiety disorders including post-traumatic stress disorder, panic disorder, and social anxiety disorder, though larger trials are needed to confirm these findings 4
Clinical Advantages in Anxiety Treatment
Rapid Onset of Action
- Mirtazapine demonstrates a statistically significantly faster onset of action compared to SSRIs (citalopram, fluoxetine, paroxetine, sertraline), which is beneficial for patients requiring rapid symptom relief 2
- Improvement in anxiety symptoms can be noted after the first week of therapy with continued improvement over subsequent weeks 5
Sleep Benefits
- Particularly useful for patients with anxiety accompanied by insomnia due to its beneficial effects on sleep disturbances 2, 6
- The sedative effects are most pronounced at lower doses (15mg) due to its antihistaminic (H1) activity 3
Safety in Special Populations
- Mirtazapine has been shown to be safe in patients with cardiovascular disease, making it a suitable option for treating anxiety in this population 1
- It can be used for sleep disturbances in patients with end-stage cardiovascular disease when cognitive behavioral therapy for insomnia is not effective 1
Dosing and Administration
- The recommended starting dosage is 15 mg/day administered as a single dose at bedtime 6
- Can be titrated up to 45 mg/day based on clinical response 5
- Sedative effects are often more pronounced at lower doses (15mg) and may decrease at higher doses 3
Efficacy in Treatment-Resistant Cases
- In treatment-resistant depression with severe generalized anxiety, adding mirtazapine to SSRI/SNRI therapy showed significant improvements in anxiety symptoms compared to placebo 7
- Patients with severe anxiety (GAD-7 ≥ 16) receiving mirtazapine had significantly lower anxiety scores at 12 weeks compared to placebo 7
Side Effect Considerations
- Most common adverse effects include somnolence, increased appetite, weight gain, and dizziness 6, 3
- Unlike SSRIs, mirtazapine does not appear to be associated with sexual dysfunction 3
- Somnolence, the most commonly reported side effect, appears to be less frequent at higher dosages 3
Clinical Decision Algorithm
First-line consideration: Use mirtazapine when anxiety co-occurs with:
Alternative use: Consider mirtazapine when:
Caution/monitoring needed: